A Phase II Protocol For Patients With Stage T1 Bladder Cancer To Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Cisplatin Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
A Phase I/II Trial Of A Combination Of Paclitaxel And Trastuzumab With Daily Irradiation Or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery For Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
A Phase II Randomized Trial For Patients With Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery And BID Irradiation Plus Either Paclitaxel And Cisplatin Or 5-Fluorouracil And Cisplatin Followed By Selective Bladder Preservation And Gemcitabine/Paclitaxel/Cisplatin Adjuvant Chemotherapy
A Phase I/II Trial In Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery Plus Taxol, Cisplatin, And BID Irradiation Followed By Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant Chemotherapy
A Phase I/II Trial In Operable Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery And Cisplatinum/ BID Irradiation Followed by Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant Chemotherapy
A Phase I/II Trial Of Transurethral Surgery Plus Induction Chemoradiotherapy Followed By Either Selective Bladder Preservation Or Radical Cystectomy As Determined By Initial Response And Operability In Patients With Muscle-Invading Bladder Cancer
A Phase III Trial To Study The Role of Neoadjuvant MCV Chemotherapy Combined With Transurethral Surgery Plus Cisplatin With Radiation Therapy For Selective Bladder Preservation In Patients With Muscle-Invading Bladder Cancer
Phase I/II Study of Neoadjuvant Chemotherapy with MCV (MTX/CDDP/VBL) with Intraoperative Electron Beam Radiotherapy and Pre- and Postoperative External Beam Radiotherapy in Patients with Invasive Bladder Carcinoma
Phase I/II Study of Neoadjuvant Combined Modality Treatment with Chemotherapy with MCV (MTX/DDP/VBL) plus Radiotherapy and DDP with Selective Bladder Preservation in Patients with Invasive Bladder Cancer
Phase I/II Evaluation of Twice-Daily Fractional Radiotherapy for Locally Advanced Stage B/C/D Transitional Cell and Unresectable Squamous Cell Carcinoma of the Bladder
